Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Title:
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Author:
Adra, Nabil Albany, Costantine Brames, Mary J. Case-Eads, Somer Johnson, Cynthia S. Liu, Ziyue Fausel, Christopher A. Breen, Timothy Hanna, Nasser H. Hauke, Ralph J. Picus, Joel Einhorn, Lawrence H.